• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis--authors' reply.

作者信息

Yamamoto T, Shimoyama T, Umegae S, Matsumoto K

机构信息

Inflammatory Bowel Disease Centre, Yokkaichi Hazu Medical Centre, Yokkaichi, Mie, Japan.

出版信息

Aliment Pharmacol Ther. 2016 May;43(9):1017-8. doi: 10.1111/apt.13578.

DOI:10.1111/apt.13578
PMID:27040167
Abstract
摘要

相似文献

1
Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis--authors' reply.
Aliment Pharmacol Ther. 2016 May;43(9):1017-8. doi: 10.1111/apt.13578.
2
Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis.
Aliment Pharmacol Ther. 2016 May;43(9):1016-7. doi: 10.1111/apt.13575.
3
Tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis: a retrospective observational study.他克莫司与抗肿瘤坏死因子药物治疗中度至重度活动性溃疡性结肠炎的回顾性观察研究
Aliment Pharmacol Ther. 2016 Mar;43(6):705-16. doi: 10.1111/apt.13531. Epub 2016 Jan 13.
4
Letter: biological drugs for inducing remission in ulcerative colitis - authors' reply.
Aliment Pharmacol Ther. 2014 May;39(10):1244. doi: 10.1111/apt.12724.
5
Letter: comparative efficacy of biological therapy in patients with ulcerative colitis - authors' reply.
Aliment Pharmacol Ther. 2014 Jun;39(12):1433-4. doi: 10.1111/apt.12773.
6
[Ulcerative colitis].
Nihon Rinsho. 2007 Oct 28;65 Suppl 8:512-5.
7
Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.英夫利昔单抗作为他克莫司治疗抵抗性溃疡性结肠炎的补救治疗的疗效和安全性。
J Gastroenterol Hepatol. 2010 May;25(5):886-91. doi: 10.1111/j.1440-1746.2009.06206.x.
8
Subcutaneous golimumab therapy for ulcerative colitis.皮下注射戈利木单抗治疗溃疡性结肠炎。
Gastroenterology. 2014 Jan;146(1):1-2.
9
Tacrolimus induction followed by maintenance monotherapy is useful in selected patients with moderate-to-severe ulcerative colitis refractory to prior treatment.他克莫司诱导治疗后序贯维持单药治疗对部分先前治疗难治的中重度溃疡性结肠炎患者有效。
Dig Liver Dis. 2014 Oct;46(10):875-80. doi: 10.1016/j.dld.2014.06.005. Epub 2014 Jul 8.
10
Letter: acute severe ulcerative colitis - should all patients be treated equally? Authors' reply.
Aliment Pharmacol Ther. 2014 Jan;39(1):114. doi: 10.1111/apt.12545.